Literature DB >> 26327357

Early-onset leukoencephalopathy due to a homozygous missense mutation in the DARS2 gene.

Cornelia Köhler1, Christoph Heyer2, Sabine Hoffjan3, Susanne Stemmler3, Thomas Lücke4, Charlotte Thiels4, Alfried Kohlschütter5, Ulrike Löbel6, Rita Horvath7, Stephanie Kleinle8, Anna Benet-Pages8, Angela Abicht8.   

Abstract

Mutations in the DARS2 gene are known to cause leukoencephalopathy with brainstem and spinal cord involvement and lactate elevation (LBSL), a rare autosomal recessive neurological disorder. It was originally described as juvenile-onset slowly progressive ataxia and spasticity, but recent reports suggest a broader clinical spectrum. Most patients were found to carry compound heterozygous DARS2 mutations, and only very few patients with homozygous mutations have been described so far. We present here an 8-month-old boy carrying a homozygous missense mutation in DARS2 who clinically showed severe neurological deterioration after a respiratory tract infection, followed by an almost complete remission of symptoms. This report further extends the knowledge about the clinical and molecular genetic spectrum of LBSL.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  DARS2; LBSL; Leukoencephalopathy; Magnetic resonance imaging; Mitochondriopathy

Mesh:

Substances:

Year:  2015        PMID: 26327357     DOI: 10.1016/j.mcp.2015.06.005

Source DB:  PubMed          Journal:  Mol Cell Probes        ISSN: 0890-8508            Impact factor:   2.365


  8 in total

Review 1.  Emerging mechanisms of aminoacyl-tRNA synthetase mutations in recessive and dominant human disease.

Authors:  Rebecca Meyer-Schuman; Anthony Antonellis
Journal:  Hum Mol Genet       Date:  2017-10-01       Impact factor: 6.150

Review 2.  Cerebral imaging in paediatric mitochondrial disorders.

Authors:  Josef Finsterer; Sinda Zarrouk-Mahjoub
Journal:  Neuroradiol J       Date:  2018-07-06

Review 3.  Human aminoacyl-tRNA synthetases in diseases of the nervous system.

Authors:  Jana Ognjenović; Miljan Simonović
Journal:  RNA Biol       Date:  2017-06-30       Impact factor: 4.652

4.  Perinatal Manifestations of DARS2-Associated Leukoencephalopathy With Brainstem and Spinal Cord Involvement and Lactate Elevation (LBSL).

Authors:  Julie Ngo; Jeremy W Prokop; Jason Umfleet; Laurie H Seaver
Journal:  Child Neurol Open       Date:  2021-05-25

5.  A novel DARS2 mutation in a Japanese patient with leukoencephalopathy with brainstem and spinal cord involvement but no lactate elevation.

Authors:  Keiko Shimojima; Takafumi Higashiguchi; Kanako Kishimoto; Satoko Miyatake; Noriko Miyake; Jun-Ichi Takanashi; Naomichi Matsumoto; Toshiyuki Yamamoto
Journal:  Hum Genome Var       Date:  2017-11-09

Review 6.  The immune system as a driver of mitochondrial disease pathogenesis: a review of evidence.

Authors:  Allison Hanaford; Simon C Johnson
Journal:  Orphanet J Rare Dis       Date:  2022-09-02       Impact factor: 4.303

7.  Upregulation of DARS2 by HBV promotes hepatocarcinogenesis through the miR-30e-5p/MAPK/NFAT5 pathway.

Authors:  Xian Qin; Changsheng Li; Tao Guo; Jing Chen; Hai-Tao Wang; Yi-Tao Wang; Yu-Sha Xiao; Jun Li; Pengpeng Liu; Zhi-Su Liu; Quan-Yan Liu
Journal:  J Exp Clin Cancer Res       Date:  2017-10-19

Review 8.  Mitochondrial aminoacyl-tRNA synthetase disorders: an emerging group of developmental disorders of myelination.

Authors:  Amena Smith Fine; Christina L Nemeth; Miriam L Kaufman; Ali Fatemi
Journal:  J Neurodev Disord       Date:  2019-12-16       Impact factor: 4.025

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.